28007-1-AP

antibody from Proteintech Group

Targeting: MAPK10 JNK3, p493F12, p54bSAPK, PRKM10

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

28007-1-AP

Provider

Proteintech Group

Product name

MAPK8/9/10 antibody

Antibody type

Polyclonal

Description

MAPK8/9/10 antibody (Cat. #28007-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human, Mouse and has been validated for the following applications: IHC, WB,ELISA.

Reactivity

Human, Mouse

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Selenoprotein GPX3 regulates NADPH oxidase expression by inhibiting the MAPK signaling pathway and thereby attenuating the inflammatory response in renal ischemia-reperfusion injury.

Pei J, Zhang J, Yu C, Luo J, Wen S, Hua Y, Wei G
Genes & diseases 2026 Mar;13(2):101640

---

Exploring the Potential Targets and Molecular Mechanisms of Selenomethionine to Attenuate Acute Kidney Injury Based on Network Pharmacology, Molecular Simulation Technology and Animal Experiments.

Pei J, Pan X, Zhan X, Wu M, Wang D, Yang Y, Lu F, Li Z, Tang H, An N, Peng J
Phytotherapy research : PTR 2026 Jan;40(1):100-115

---

Identification of ALDH2 as a novel target for the treatment of acute kidney injury in kidney transplantation based on WGCNA and machine learning algorithms and exploration of its potential mechanism of action using animal experiments.

Peng J, Wang S, Pan X, Wu M, Zhan X, Wang D, Zhu G, Wang W, Tang H, An N, Pei J
Frontiers in immunology 2025;16:1536800

---

Exploring potential targets and mechanisms of renal tissue damage caused by N-(1,3-dimethylbutyl)-N'-phenyl-p-phenylenediamine quinone (6-PPDQ) through network toxicology and animal experiments: A case of chronic kidney disease.

Pei J, Peng J, Wu M, Zhan X, Wang D, Zhu G, Wang W, An N, Pan X
The Science of the total environment 2025 Feb 10;964:178626

---

VSIG4 inhibits RANKL-induced osteoclastogenesis by enhancing Nrf2-dependent antioxidant response against reactive oxygen species production.

Miao J, Tu Y, Jiang J, Ren R, Wu Q, Liang H, Wang T, Lin B, Wu J, Pan Y, Wang X, Jin H
International journal of biological macromolecules 2024 Mar;260(Pt 2):129357

---

Molecular mechanisms and potential targets of lycopene for alleviating renal ischemia-reperfusion injury revealed by network pharmacology and animal experiments.

Pan X, Zhu R, Peng J, Liu H, Pan W, Jin Y, Pei J, Zhang L
International immunopharmacology 2024 Dec 25;143(Pt 2):113421

---

SARS-CoV-2 N protein-induced Dicer, XPO5, SRSF3, and hnRNPA3 downregulation causes pneumonia.

Luo YW, Zhou JP, Ji H, Xu D, Zheng A, Wang X, Dai Z, Luo Z, Cao F, Wang XY, Bai Y, Chen D, Chen Y, Wang Q, Yang Y, Zhang X, Chiu S, Peng X, Huang AL, Tang KF
Nature communications 2024 Aug 13;15(1):6964